Innoviva, Inc. (INVA)
21.00
+0.23
(+1.11%)
USD |
NASDAQ |
Sep 01, 15:09
Innoviva Cash from Operations (Annual) : 196.93M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 196.93M |
| December 31, 2024 | 188.69M |
| December 31, 2023 | 141.06M |
| December 31, 2022 | 201.73M |
| December 31, 2021 | 363.81M |
| December 31, 2020 | 313.11M |
| December 31, 2019 | 257.46M |
| December 31, 2018 | 223.53M |
| December 31, 2017 | 141.75M |
| December 31, 2016 | 60.98M |
| December 31, 2015 | 10.13M |
| December 31, 2014 | -130.72M |
| December 31, 2013 | -129.60M |
| Date | Value |
|---|---|
| December 31, 2012 | -127.95M |
| December 31, 2011 | -88.34M |
| December 31, 2010 | -75.14M |
| December 31, 2009 | -58.06M |
| December 31, 2008 | -99.91M |
| December 31, 2007 | -104.37M |
| December 31, 2006 | -104.79M |
| December 31, 2005 | -58.64M |
| December 31, 2004 | -47.82M |
| December 31, 2003 | -31.68M |
| December 31, 2002 | -58.60M |
| December 31, 2001 | -47.69M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Zevra Therapeutics, Inc. | -1.598M |
| Collegium Pharmaceutical, Inc. | 329.32M |
| CorMedix, Inc. | 175.05M |
| ANI Pharmaceuticals, Inc. | 185.22M |
| Corcept Therapeutics, Inc. | 142.00M |